These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30160917)

  • 21. [Treatment of gout in patients with chronic kidney disease].
    Bertrand J; Genevay S; Saudan P
    Rev Med Suisse; 2011 Mar; 7(284):483-6, 488-9. PubMed ID: 21462517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
    Dalbeth N; Doyle A; McQueen FM
    Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperuricemia, gout, pseudogout and concomitant diseases].
    Schmidt BM; Wagner AD
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2489-91. PubMed ID: 22109583
    [No Abstract]   [Full Text] [Related]  

  • 24. [The necessity and importance of standardized diagnosis and treatment of gout].
    Zou HJ
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):412-413. PubMed ID: 32486578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.
    JAMA; 2018 Jan; 319(2):188-189. PubMed ID: 29318274
    [No Abstract]   [Full Text] [Related]  

  • 26. [Management of hyperuricemia in occupational health: with reference to "guidelines for the management of hyperuricemia and gout"].
    Nakajima H
    Sangyo Eiseigaku Zasshi; 2003 Jan; 45(1):12-9. PubMed ID: 12624869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consider gout in patients with risk factors, regardless of age.
    Olaniyi-Leyimu BY
    Am Fam Physician; 2008 Jul; 78(2):176. PubMed ID: 18697500
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on Importance of Diet in Gout.
    Beyl RN; Hughes L; Morgan S
    Am J Med; 2016 Nov; 129(11):1153-1158. PubMed ID: 27452679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The management of gout].
    Peters C; Malaise O; Longton J; André B; Ribbens C
    Rev Med Liege; 2023 Dec; 78(12):733-739. PubMed ID: 38095039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why better treatment of gout is needed.
    So AK
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
    Schils R; Krzesinski JM
    Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S50-6. PubMed ID: 21654270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT; Pillinger MH
    Bull NYU Hosp Jt Dis; 2009; 67(3):285-90. PubMed ID: 19852752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperuricemia and gout: new concepts in diagnosis and management.
    Doghramji PP; Wortmann RL
    Postgrad Med; 2012 Nov; 124(6):98-109. PubMed ID: 23322143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976
    [No Abstract]   [Full Text] [Related]  

  • 37. [The interpretation of 2018 updated European League Against Rheumatism evidence based recommendations for the diagnosis of gout].
    Zeng XJ; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2019 Oct; 58(10):745-750. PubMed ID: 31594172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperuricemia. IX. Complications of hyperuricemia. On the treatment of hyperuricemia].
    Ryckewaert A; Dry J; Paolaggi F
    Rev Rhum Mal Osteoartic; 1967 Nov; 34(11):659-63. PubMed ID: 5597156
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.
    Becker MA; MacDonald PA; Hunt B; Gunawardhana L
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1011-7. PubMed ID: 22132950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coexistence of systemic sclerosis and gout? Hyperuricemia in systemic sclerosis: case report and literature review].
    Madej M; Morgiel E; Łuczak A; Kowalewska B; Wiland P
    Ann Acad Med Stetin; 2012; 58(1):28-32; discussion 32. PubMed ID: 23547391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.